Loading…
ChemPartner is a global CRO/CDMO providing end-to-end biopharmaceutical R&D, spanning discovery chemistry through biology, DMPK/tox, analytical, and regulatory support. They offer comprehensive biologics discovery and CMC/CDMO capabilities—including antibody discovery, protein science, cell line development, manufacturing process development, pilot-scale production, and cGMP manufacturing—to advance programs from concept to IND filing. With facilities such as the Boston Center of Excellence and a broad portfolio of services, ChemPartner focuses on delivering high-quality, timely, and cost-effective drug development.
AI named ChemPartner from December 2025 to February 2026.